Registry of all Projects in Switzerland (RAPS)

Registry database of all projects approved by the ethics committees in Switzerland

Lead EC
  •  Comitato etico cantonale Ticino
  •  Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD)
  •  Commission Cantonale d'éthique de la recherche Genève (CCER)
  •  Ethikkommission Nordwest- und Zentralschweiz EKNZ
  •  Ethikkommission Ostschweiz (EKOS)
  •  Kantonale Ethikkommission Bern
  •  Kantonale Ethikkommission Zürich
  • Apply
Type of project
  •  clinical trial
  •  deceased persons
  •  non clinical, involving persons
  •  personal data/biological material
  • Apply
Category
Study phase (clinical trials only)
  •  n/a
  •  phase 1
  •  phase 1/2
  •  phase 2
  •  phase 3
  •  phase 4
  • Apply
multi- / monocentric
Study Ended
Displaying 1 - 20 of 7066
BASEC ID Project title Type of project Category Study phase (clinical trials only) Principal investigator Sponsor multi- / monocentric Lead EC Local EC(s) Investigational sites Approval date Study Ended
2016-00033 Human fetal midbrain and inner ear tissues to develop new regenerative therapy forms for Parkinson's disease and hearing loss Prof. Dr. phil. Hans Rudolf Widmer monocentric Kantonale Ethikkommission Bern University of Bern, Bern 17.01.2017
2016-00175 Etude de l'expression des facteurs de croissances fibroblastiques, mésenchymateux, épithéliaux et endothéliaux dans le poumon de foetus humains sains. Dr Isabelle Ruchonnet-Métrailler monocentric Commission Cantonale d'éthique de la recherche Genève (CCER) Département d'Immunologie et Pathologie, Genève 05.04.2016
2015-00010 Cytokine Clearance with Cytoabsorbant Device during Cardiac Bypass: a Pilot Study clinical trial A Dr Antoine Schneider CHUV monocentric Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) CHUV, Lausanne 12.04.2016 Study has ended
2015-00011 Diagnostic performance of an automated breast ultrasound system (ABUS): a single centre study clinical trial A PD Dr. med. Dr. sc. hum. Andreas Boss monocentric Kantonale Ethikkommission Zürich Institut für Interventionelle und diagnostische Radiologie USZ, Zürich 12.01.2016
2015-00012 Mixed methods study to test the efficacy of the adapted German PRO-SELF© Plus Pain Control Program, an intervention directed at outpatients with cancer and their family caregivers to reduce pain and r More ... clinical trial A PD Dr. Elisabeth Spichiger multicentric Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern Kantonale Ethikkommission Zürich University Basel, Medical Faculty, Institute of Nursing Science, Basel
Inselspital Bern, University Hospital, Department of Nursing/MTT, Bern
29.03.2016 Study has ended
2015-00020 SINGLE CENTER, OPEN-LABEL, PROSPECTIVE STUDY TO CHARACTERIZE THE PHARMACOKINETICS OF METAMIZOLE AND ITS METABOLITES FOLLOWING INTRAVENOUS ADMINISTRATION IN CHILDREN LESS THAN 6 YEARS OLD clinical trial B phase 2 Prof. Marc Pfister monocentric Ethikkommission Nordwest- und Zentralschweiz EKNZ University of Basel Childrens Hospital, Basel 05.01.2016 Study has ended
2015-00023 GS-US-326-1100: A Combined Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluating the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severel More ... clinical trial C phase 2 Prof. Dr Gerhard Rogler Gilead Sciences multicentric Kantonale Ethikkommission Zürich Kantonale Ethikkommission Bern Ethikkommission Nordwest- und Zentralschweiz EKNZ USZ, Zürich
Gastroenterologische Praxis Balsiger, Seibold & Partner, Bern
USB Gastroenterologie und Hepathologie, Basel
18.03.2016
2015-00024 Effects of empagliflozin an SGLT2-inhibitor on healthy volunteers with induced hypotonic hyponatremia - the DIVE-study clinical trial C n/a Prof / Mirjam / Christ Endokrinologie, Universitätsspital Basel monocentric Ethikkommission Nordwest- und Zentralschweiz EKNZ Endocrinology, Basel 08.01.2016 Study has ended
2015-00031 Double-blind, randomized, placebo-controlled, phase III study on the efficacy and tolerability of a 48-week treatment with two different doses of budesonide effervescent tablets vs. placebo for mainte More ... clinical trial C phase 3 Dr. med. Alain Schoepfer Dr. Falk Pharma GmbH multicentric Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Zürich University Hospital Lausanne/CHUV Division of Gastroenterology and Hepatology, Lausanne
Praxis für Gastroenterologie, Römerstraße 7, CH-4600 Olten
Universitätsklinik Basel Abteilung für Gastroenterolo More ...
25.05.2016
2015-00032 The effect of biopolymer based lipid emulsions on GI function, GI peptide response
and satiation in healthy volunteers; a randomized, double blind, unbalanced threeway crossover study.
clinical trial B Dr. Andreas Setingoetter monocentric Kantonale Ethikkommission Zürich University Hospital Zurich, Zurich 01.04.2016 Study has ended
2015-00033 A Phase I/II, multicenter, open-label, dose-escalation study of the safety and pharmacokinetics of cobimetinib in pediatric and young adult patients with previously treated solid tumors clinical trial C phase 1 Dr. Nicolas Gerber F. Hoffmann-La Roche Ltd. monocentric Kantonale Ethikkommission Zürich Universitäts-Kinderspital, Zürich 15.07.2016 Study has ended
2015-00034 Prevalence of HPV infection using self-sampling screening and monitoring the Earlier Impact of HPV-Vaccination Program in Switzerland clinical trial A Prof Patrick Petignat Geneva university hospital monocentric Commission Cantonale d'éthique de la recherche Genève (CCER) Hopital universitaire de Geneve, geneva 05.01.2016 Study has ended
2015-00039 BIOTRONIK – Safety and clinical performance of the self-expanding transcatheter BIOVALVE prosthesis in subjects with severe symptomatic calcified aortic valve stenosis suitable for transfemoral transc More ... clinical trial C Prof. Dr.med Francesco Maisano BIOTRONIK AG - Clinical Affairs monocentric Kantonale Ethikkommission Zürich UniversitätsSpital Zürich - Klinik für Herz- und Gefässchirurgie, Zürich 08.03.2016
2015-00040 A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled,
Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in
Subjects with Nonalcoholic Steatohepatitis
clinical trial C phase 3 Prof.Dr.Jean-Francois Dufour Intercept Pharma Switzerland GmbH multicentric Kantonale Ethikkommission Bern Ethikkommission Ostschweiz (EKOS) Comitato etico cantonale Ticino Kantonale Ethikkommission Zürich University Clinic of Visceral Surgery and Medicine, Bern
Kantonsspital St. Gallen, St. Gallen
EPATOCENTRO TICINO, Lugano
01.06.2016
2015-00042 SAKK 16/14
Anti-PD-L1 antibody MEDI4736 in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC). A multicenter single-arm phase II trial.
clinical trial C phase 2 Dr. med. Sacha Rothschild SAKK multicentric Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern Ethikkommission Nordwest- und Zentralschweiz EKNZ Commission Cantonale d'éthique de la recherche Genève (CCER) Ethikkommission Ostschweiz (EKOS) Comitato etico cantonale More ... Universitätsspital Basel, Basel
Inselspital Bern, Bern
Spital STS AG Thun, Thun
Hôpitaux Universitaires de Genève, Genève
Kantonspital Aarau, Aarau
Kantonsspital Baden, Baden
Luzerner Kantonsspital, L More ...
30.03.2016
2015-00043 M13-545: A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 Once Daily Monotherapy to Methotrexate (MTX) Monotherapy in MTX-Naïve Subjects with Moderately to Severely Active Rheumatoid Arthri More ... clinical trial C phase 3 Prof. Dr. Jean Dudler AbbVie AG monocentric Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Service de rhumatologie HFR Fribourg – Hôpital Cantonal, Fribourg 14.03.2016
2015-00044 M13-549: A Phase III, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who Are on a Stable Dose of Conventional Synthetic More ... clinical trial C phase 3 Prof. Dr. Jean Dudler AbbVie AG multicentric Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Ethikkommission Nordwest- und Zentralschweiz EKNZ HFR Kantonsspital Freiburg, Rheumatologie, 1708 Freiburg
Kantonsspital Aarau, Abteilung Rheumatologie, Aarau
23.02.2016
2015-00055 Assessment of psychological and metabolic responses during fructose intolerance breath tests in patients with functional GI disorders: placebo-controlled breath testing clinical trial A Dr. med Clive Wilder-Smith monocentric Kantonale Ethikkommission Bern Brain-Gut-Research Group/Gastroenterology Group Practice, Bern 17.05.2016 Study has ended
2015-00057 GA29144 - A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF
ETROLIZUMAB AS AN INDUCTION AND MAINTENANCE TREATMENT FOR PATIENTS WITH MO More ...
clinical trial C phase 3 Prof. Dr. Stephan Brand F. Hoffmann-La Roche Ltd. multicentric Ethikkommission Ostschweiz (EKOS) Kantonale Ethikkommission Bern Kantonale Ethikkommission Zürich Kantonsspital St. Gallen, St. Gallen
Inselspital Bern, Bern
Crohn-Colitis Zentrum Bern, Bern
15.03.2016
2015-00059 Sienna+® Injection Time Pilot Study: A prospective observational multicentre, controlled clinical trial to evaluate the performance of superparamagnetic iron oxide vs. standard technique as tracer in More ... clinical trial A PD Dr. Cornelia Leo multicentric Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern Kantonsspital Baden AG, Baden
Universitätsklinik für Frauenheilkunde, Inselspital, Bern
05.10.2016